CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Abstract

As the differential diagnosis of dementias based on established clinical criteria is often difficult, biomarkers for applicablediagnostictestingarecurrentlyunder intensive investigation.Amyloidplaquesdeposited inthebrainof patients suffering fromAlzheimer’s disease,dementiawithLewybodies (DLB)andParkinson’s diseasedementia (PDD) mainly consist of carboxy… (More)

Topics

7 Figures and Tables

Cite this paper

@inproceedings{Bibl2006CSFAI, title={CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia}, author={Mirko Bibl and B. A. Mollenhauer and Hermann Esselmann and Piotr Lewczuk and H. Klafki and Katrin Sparbier and Alexandr Smirnov and Lukas Cepek and Claudia Trenkwalder and Eckart Ruether and Johannes Kornhuber and Markus Otto and Jens Wiltfang}, year={2006} }